From your link... People who have previously recovered from COVID-19 have a stronger immune response after being vaccinated than those who have never been infected. Scientists are trying to find out why.
So what is the problem? My point is that natural immunity ALONE is insufficient. Is there a communication problem here? I am responding to the anti vaxx crap that I am hearing. Are you saying that you are not anti vax?
My position will not change unless we suddenly learn that ALL antibody tests have been bogus and antibodies from injection route are secretly working much longer than testing out at 4-5 months on average. Natural immunity provides much longer protection from antibodies compared to the previous short-lived protection by the rushed “vaccines”.
You have to have a major faith in 3 pharmas that have never once produced a vaccine in their companies history to believe them over Merck- a top producer of successful US vaccines determined no vaccine route was superior.
Here is a valid solution that will soon be out to the public, if not already by Merck.
Merck’s own SARS2 testing (superior without question due to vaccine hx alone) found that a no vaccine route was superior to a vaccine route. Merck knew these rushed, inferior products would fail, otherwise they would have pursued it.
I intentionally used a political left-leaning source to up the odds you’ll consider it more thoroughly. Political commentary, however, should stay out of the conversation.
An antiviral pill found to be effective at treating Covid-19 has been approved by Britain's medicines regulator.
www.cnbc.com
A better source for readers uninterested in political commentary about medicinal options:
Merck says its drug, molnupiravir, stops viral replication and can be taken right after a COVID-19 diagnosis.
www.sciencenews.org
Relevant to the discussion:
“At Merck, we have a rich legacy in vaccine manufacturing and look forward to
combining our expertise with Johnson & Johnson to help increase supply and expand access to authorised SARS-CoV-2/COVID-19 vaccines,” said Sanat Chattopadhyay, executive vice president and president, Merck Manufacturing Division.”
Merck will achieve their goal to add jobs at their factories by helping Johnson and Johnson with its product. It will be interesting to learn if Merck will tweak the J&J product with sharing expertise? I wonder if the other 2 pharmas using messenger RNA (unlike J&J) attempted any manufacturing deals with Merck?
“Merck & Co said that it will continue to advance clinical programmes for two novel therapeutics targeting SARS-CoV-2, the virus which causes COVID-19.”
Company has signed agreements to bolster vaccine manufacturing capacity
www.pmlive.com